The co-chairs for patients, science and industry of the EPPOSI (European Platform for Patients’ Organisations, Science and Industry) conference held in Dublin recently have called for much greater collaboration between patient organisations, science, industry and regulatory bodies in the development of new treatments that represent valuable innovation.
Board member representing academic science, Ivan Baines said: “Because industry and regulation work in such isolation from each other – and because of the real likelihood that much of the work they do is needlessly duplicated – I believe health systems in Europe could make spectacular savings if these groups worked together to ensure that duplicated testing and analysis was kept to a minimum.”
